Search

In Stock

Buy Xeljanz : Tofacitinib 5 mg Tablets Online

Brand Name: Xeljanz
Composition: Tofacitinib
Manufactured by: Pfizer Pharmaceuticals, Inc.
Strength: 5 mg
Form: Tablets
Packing: Pack of 60 Tablets

Prescription Required *

$417.52

Compare

Xeljanz is a pharmaceutical medication that contains the active ingredient tofacitinib. It is part of a class of medications known as Janus kinase (JAK) inhibitors and is primarily used to treat autoimmune diseases, particularly rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. Tofacitinib works by targeting specific enzymes in the immune system, helping to reduce inflammation and manage the symptoms associated with these conditions.

Here is a detailed description of Xeljanz:

Active Ingredient:

  • Tofacitinib: Tofacitinib is a Janus kinase inhibitor that acts by selectively inhibiting JAK enzymes, specifically JAK1 and JAK3. These enzymes are involved in the signaling pathways that contribute to inflammation. By blocking JAK1 and JAK3, tofacitinib helps reduce the inflammatory response, alleviating the symptoms of autoimmune diseases.

Indications:

Xeljanz is indicated for the treatment of the following medical conditions:

  1. Rheumatoid Arthritis (RA): Xeljanz is used to treat moderate to severe rheumatoid arthritis in adult patients who have not responded well to other disease-modifying antirheumatic drugs (DMARDs).
  2. Psoriatic Arthritis: It is also used to treat psoriatic arthritis, an inflammatory joint condition that occurs in some individuals with psoriasis.
  3. Ulcerative Colitis: Xeljanz is indicated for the treatment of moderately to severely active ulcerative colitis in adult patients who have not responded well to conventional therapies.

Usage:

The dosing and administration of Xeljanz are determined by a healthcare provider and depend on the specific condition being treated. It is typically taken orally in the form of tablets, with the 5 mg tablets being a common dose, usually taken twice daily.

Mechanism of Action:

Tofacitinib, the active ingredient in Xeljanz, works by selectively inhibiting JAK1 and JAK3, key enzymes in the inflammatory signaling pathways. By targeting these enzymes, tofacitinib interferes with the inflammatory response, helping to reduce joint pain, swelling, and inflammation in autoimmune diseases and alleviate symptoms in ulcerative colitis.

Benefits:

Xeljanz offers the benefit of effectively managing autoimmune diseases, including rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. It can help reduce inflammation, alleviate joint pain, improve mobility, and enhance the overall quality of life for patients.

Precautions:

Before starting Xeljanz, patients should undergo a thorough evaluation by a healthcare provider. It is essential to inform the healthcare provider of any allergies, medical conditions, or other medications being taken, as these factors can affect the safety and efficacy of the medication.

Side Effects:

Common side effects of Xeljanz may include upper respiratory tract infections, headache, and increased liver enzyme levels. Patients may also be at a slightly increased risk of infections while taking Xeljanz. Patients should discuss any side effects or concerns with their healthcare provider.

In conclusion, Xeljanz (tofacitinib 5 mg tablets) is a medication used to treat autoimmune diseases, including rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. It works by selectively inhibiting JAK1 and JAK3 enzymes, which are involved in the inflammatory process. Patients should use it as directed by their healthcare provider and be aware of potential side effects and precautions associated with its use.

Reviews

There are no reviews yet.

Write a review

Your email address will not be published. Required fields are marked *

Bestsellers

Buy Stelara (ustekinumab) Injection Online

From $5,034.51
(0 Reviews)
Stelara, known by its generic name Ustekinumab, is a prescription medication used in the treatment of certain autoimmune diseases, primarily plaque psoriasis, psoriatic arthritis, and Crohn's disease.

Buy Skyrizi (Risankizumab) Online

From $14,517.47
(0 Reviews)
DISEASE INDICATIONS: Psoriasis MANUFACTURER: AbbVie Ltd USAGE: Subcutaneous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Therapeutic Goods Administration (TGA) Skyrizi (risankizumab) is a prescription medication used to treat moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. It is a monoclonal antibody that works by blocking the interleukin-23 (IL-23) pathway, which is involved in the development and progression of psoriasis.

Buy Tremfya (guselkumab) Online

$2,860.64
(0 Reviews)
DISEASE INDICATIONS: Psoriasis MANUFACTURER: Janssen Biotech USAGE: Subcutaneous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Health Canada Pharmaceuticals and Medical Devices Agency (PMDA) Therapeutic Goods Administration (TGA) Tremfya is a pharmaceutical medication that contains the active ingredient guselkumab. It belongs to a class of medications known as interleukin-23 (IL-23) inhibitors and is primarily used in the treatment of certain chronic skin conditions, particularly moderate to severe plaque psoriasis. Guselkumab works by targeting specific proteins in the immune system that play a role in the development of psoriatic skin lesions, thereby reducing the symptoms associated with this condition.

Buy Rinvoq (upadacitinib) Online

$1,955.31
(0 Reviews)
Rinvoq is a pharmaceutical medication that contains the active ingredient upadacitinib. It belongs to a class of medications known as Janus kinase (JAK) inhibitors and is primarily used to treat autoimmune diseases, particularly rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. Upadacitinib works by targeting specific enzymes in the immune system, helping to reduce inflammation and alleviate the symptoms associated with these conditions.

Buy Taltz (ixekizumab) Online

From $2,499.58
(0 Reviews)
DISEASE INDICATIONS: Psoriasis MANUFACTURER: Eli Lilly Nederland B.V. USAGE: Subcutaneous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Health Canada Therapeutic Goods Administration (TGA) Taltz (ixekizumab) is a prescription medication used to treat moderate to severe plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis in adults. It is a monoclonal antibody that works by blocking interleukin 17A (IL-17A), a cytokine that plays a key role in the development and progression of these inflammatory diseases.

Buy Olumiant (baricitinib) Online

From $1,070.33
(0 Reviews)
DISEASE INDICATIONS: Rheumatoid Arthritis MANUFACTURER: Eli Lilly Nederland B.V. USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Olumiant (baricitinib) is a prescription medication used to treat rheumatoid arthritis (RA), alopecia areata, and COVID-19. It is a Janus kinase (JAK) inhibitor, which means that it blocks the activity of JAK enzymes. JAK enzymes are involved in the signaling pathway that leads to inflammation.

Buy Tymlos (abaloparatide) Online

$2,636.72
(0 Reviews)
DISEASE INDICATIONS: Osteoporosis MANUFACTURER: Radius Health, Inc. USAGE: Subcutaneous MEDICINE APPROVED BY: Food and Drug Administration (FDA) Tymlos is a prescription medication used to treat osteoporosis, a condition characterized by the weakening of bones, which can lead to an increased risk of fractures and bone fractures. It is specifically indicated for postmenopausal women at high risk of fracture or those who have failed other osteoporosis treatments.

Back to Top
Product has been added to your cart